GSK PLC SP. ADR/2 NEW (GS70) — Cash Flow Quality Index
GSK PLC SP. ADR/2 NEW (GS70) has a Cash Flow Quality Index of 0.66x as of March 2026. Operating cash flow of €1.14 Billion is below net income of €1.74 Billion, suggesting accrual-heavy earnings not yet converted to cash. Also explore how large is GSK PLC SP. ADR/2 NEW's balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GSK PLC SP. ADR/2 NEW Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for GSK PLC SP. ADR/2 NEW across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GSK PLC SP. ADR/2 NEW tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for GSK PLC SP. ADR/2 NEW (2021–2025)
Year-by-year earnings quality comparison for GSK PLC SP. ADR/2 NEW. For live market cap and the full company financial profile, see GSK PLC SP. ADR/2 NEW (GS70) market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.35x | €7.74 Billion | €5.72 Billion | ▼ -46.8% |
| 2024 | 2.55x | €6.55 Billion | €2.58 Billion | ▲ +85.3% |
| 2023 | 1.37x | €6.77 Billion | €4.93 Billion | ▲ +177.5% |
| 2022 | 0.49x | €7.40 Billion | €14.96 Billion | ▼ -72.7% |
| 2021 | 1.81x | €7.95 Billion | €4.38 Billion | — |